Management of uterine leiomyomata: What do we really know?

Obstetrics and Gynecology

Volumn 100, Issue 1, 2002, Pages 8-17

  Myers, Evan R ^a,b   Barber, Matthew D ^a,b   Gustilo Ashby, Tara ^a,b   Couchman, Grace ^a,b   Matchar, David B ^a,b   McCrory, Douglas C ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOAVAILABILITY; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; DISEASE SEVERITY; EMBASE; HUMAN; HYSTERECTOMY; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; META ANALYSIS; MYOMECTOMY; PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; RETROSPECTIVE STUDY; REVIEW; UTERINE LEIOMYOMATA; UTERUS MYOMA;

ADULT; CONTROLLED CLINICAL TRIALS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYSTERECTOMY; LASER SURGERY; LEIOMYOMA; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0036298307     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02019-7     Document Type: Review

References (83)

1. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race
2. Hysterectomy surveillance - United States 1980-1993
3. The appropriateness of recommendations for hysterectomy
4. Identifying relevant studies for systematic reviews
5. Meta-analysis of observational studies in epidemiology: A proposal for reporting
6. Follow up of hysteroscopic surgery for menorrhagia
7. Dilute ornitin vasopressin and a myoma drill for laparoscopic myomectomy
8. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas
9. Transcervical resection of fibroids (TCRM): Results related to hysteroscopic classification
10. Hysteroscopic treatment of uterine fibroids
11. The excision of uterine fibroids by vaginal myomectomy: A prospective study
12. Determinants of reproductive outcome after abdominal myomectomy for infertility
13. Fertility and fetal salvage among women with uterine leiomyomas in a Nigerian Teaching Hospital
14. Resectoscopic removal of symptomatic intrauterine lesions
15. Removing a large submucous fibroid hysteroscopically with the two-resectoscope method
16. Endometrial ablation for the treatment of menorrhagia: A comparison of patients with normal enlarged and fibroid uteri
17. Laparoscopic myomectomy
18. Removal of large symptomatic intrauterine growths by the hysteroscopic resectoscope
19. Abdominal myomectomy and subsequent fertility
20. Fertility after hysteroscopic myomectomy: Effect of intramural myomas associated
21. Argon beam coagulator for laparoscopic myomectomy
22. Hysteroscopic management of submucous uterine myomata
23. Neodymium: YAG laser hysteroscopy in large submucous fibroids
24. Low power interstitial photocoagulation of uterine leiomyomas by KTP/NAG laser
25. Laparoscopically assisted myomectomy: A report of a new technique in 57 cases
26. Morbidity associated with abdominal myomectomy
27. Hysteroscopic treatment of menorrhagia associated with uterine leiomyomas
28. Submucous fibroids: Clinical profile and hysteroscopic management
29. Laparoscopic myomectomy
30. Resectoscopic myomectomy
31. Hysteroscopic treatment of symptomatic submucous myomata uteri with the Nd:YAG laser
32. Fertility after hysteroscopic resection of submucous myomas
33. Methodical intrauterine resection
34. Hysteroscopic resection of fibroids: Results with a 6-year follow-up period
35. Long-term follow-up of hysteroscopic myomectomy assessed by survival analysis
36. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding
37. Caesarean myomectomy - A safe procedure. A retrospective case controlled study
38. Uterine myomas: Pelviscopic treatment
39. Regression of residual tissue after incomplete resection of submucous myomas
40. Laparoscopic myomectomy in African-American women
41. Features of uterine fibroids treated by abdominal myomectomy at Nnewi Nigeria
42. Abdominal myomectomy is associated with few surgical complications
43. Recurrence rate after laparoscopic myomectomy
44. Transcervical electrosurgical resection of submucous leiomyomas for chronic menorrhagia
45. Fertility after laparoscopic myomectomy: Preliminary results
46. Laparoscopic myomectomy: Indications surgical technique and complications
47. Laparoscopic myomectomy: Time and cost analysis of power vs. manual morcellation
48. Difficulties and complications of laparoscopic myomectomy
49. The results of abdominal myomectomy
50. Immediate and late outcome of vaginal myomectomy for prolapsed pedunculated submucous myoma
51. New therapeutic technique for treatment of uterine leiomyomas using laser-induced interstitial thermotherapy (LITT) by a minimally invasive method
52. Single-stage total hysteroscopic myomectomies: Indications techniques and results
53. Recurrence of fibroids after myomectomy: A transvaginal ultrasonographic study
54. Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo
55. The Maine Women's Health Study: I. Outcomes of hysterectomy
56. Effectiveness of hysterectomy
57. Functional outcomes and satisfaction after abdominal hysterectomy
58. Myomectomy fever: Testing the dogma
59. Abdominal hysterectomy or abdominal myomectomy for symptomatic leiomyoma: A comparison of preoperative demography and postoperative morbidity
60. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas
61. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas abnormal bleeding and chronic pelvic pain
62. Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind placebo-controlled multicenter study. The Leuprolide Study Group
63. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata
64. Gonadotropin-releasing hormone analog treatment should not precede conservative myomectomy
65. Effect of tibolone on postmenopausal woman with myomas
66. Efficacy of leuprorelin acetate depot in symptomatic fibromatous uteri: The Italian Multicentre Trial
67. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata
68. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: The possibility of nonsurgical management in selected perimenopausal women
69. Clinical predictors for buserelin acetate treatment of uterine fibroids: A prospective study of 40 women
70. Treatment of leiomyomata with intranasal or subcutaneous leuprolide a gonadotropin-releasing hormone agonist
71. Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: Effectiveness and effects on vasomotor symptoms bone mass and lipid profiles
72. Short-term treatment with leuprolide acetate is a successful adjunct to surgical therapy of leiomyomas of the uterus
73. Long-term medical therapy for leiomyomata uteri: A prospective randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years
74. Treatment of peri-menopausal women: Potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy
75. Bleeding patterns in recent postmenopausal outpatients with uterine myomas: Comparison between two regimens of HRT
76. Decrease in symptoms blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: A placebo-controlled double-blind study
77. Administration of preoperative gonadotropin releasing hormone agonist (buserelin) for uterine leiomyomas
78. Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?
79. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia
80. The UFS-QOL a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata